Global leader in metabolomics for drug development, biomarker discovery, and advancing microbiome, pharma & life sciences research.
Research Triangle Park, NC
Joined February 2010
- Tweets3.1K
- Following1.2K
- Followers2.7K
- Likes2.4K
Generating molecular data is one thing. Turning it into biological insights is another.
How can metabolomics help bridge that gap?
Explore how Splash & Ripple supports the journey from biochemical data to mechanistic hypotheses.
🔗bit.ly/4yHo8L3
Science is advancing animal health, too! 🐶
Brian shares how researchers from Hill's Pet Nutrition, MIT and Harvard used metabolomics to reveal how dietary fibre influences gut microbial metabolism in dogs, with responses varying between individuals.
#PeakScience #Metabolomics
It's been a busy #ASHG26! 🧬
Thanks to everyone who's stopped by to discuss metabolomics, genomics and our newest bioinformatics application, Splash & Ripple.
Still in Montréal? Meet the Metabolon team at Booth #620!
How reproducible is Metabolon Verus™ across labs?
A ring trial across 8 independent labs showed 89% average metabolite overlap and a 0.91 median correlation with quantitative targeted panels.
Explore the results: bit.ly/4seyqAM
Introducing Splash & Ripple: connect metabolite changes to candidate protein and move from metabolomic changes to testable multiomic hypotheses.
Find out more: bit.ly/4i6PLXB
During COVID-19, dormant viruses can reactivate. What does this mean for patients?
A study of 1,154 patients used Metabolon’s platform to reveal metabolic changes associated with viral reactivation.
Where else could biochemical profiling help us understand infection & recovery?
Great first day in Basel! 🙌 Thanks to everyone who visited Metabolon to discuss resolving biology through biochemical profiling.
Looking forward to more conversations tomorrow! See you at booth #33.
#BIOMEU2026 #NGOEU2026 #OGPREMED
How can lipidomics help resolve disease biology?
Join Metabolon’s Natasa Giallourou at LIPID MAPS Training School 2026 to explore complex lipids in health, disease & therapeutic development.
📅 15 Oct | 17:25 BST
bit.ly/4c4njV5
What’s the most important unanswered question in diabetes research?
At #EASD2026, Dr. Denise Faustman shared why looking beyond blood glucose matters, and how metabolomics can help resolve the underlying biology.
▶️ Watch her perspective.
Let’s meet in Basel! Visit Metabolon at Booth #33, 13–14 October, for Biomarkers & NextGen Omics.
Catch a presentation on pancreatic cancer metabolite signatures and a poster on multiomic insights into neonatal encephalopathy.
#BIOMEU2026 #NGOEU2026 #OGPREMED
ALT The image is a promotional banner for the "Biomarkers, CDx & Precision Medicine Europe 2026" event, taking place in Basel, Switzerland, on 13-14 October 2026. It highlights that Group 4S is sponsoring the event. The text reads "Let's Connect!" with a highlighted "Booth #33." Additional text encourages visiting their presentations during the event.
ALT The image is a promotional flyer for an oral presentation at the Biomarkers, CDx & Precision Medicine Europe 2023 event. The topic is "Prospective Diagnostic Validation of Two Plasma Multi-Metabolite Signatures in an Enrichment Design for Patients with Suspected or at Risk of Pancreatic Cancer". Details include the date, Saturday, 14 October; the time, 12:35 – 13:00; and the location, Conference Room 1. A speaker is shown with affiliation to NIPER and LMU Klinikum.
ALT An event poster for "NextGen Omics Tech & Data 2023" showcases a presentation on metabolomics in neonatal encephalopathy. The poster features details such as the event date, October 13-14, location in the poster area, and highlights Joe Forster from Metabolon as the speaker.
At #EASD2026? Meet Metabolon at booth Q.03!
Diabetes is more than glucose. Discover how metabolomics can support risk assessment, patient stratification, and research into disease mechanisms and treatment response.
Stop by and tell us about your research!
What can we learn by connecting the layers of biology? 🧬
Our new Guide to Multiomics shows how metabolomics adds biochemical context, with case studies and methods including machine learning and data harmonization.
Read the guide: bit.ly/4Aw468o
Let’s meet in Milan!
We’re exhibiting at #EASD2026 to share how metabolomics can advance risk assessment, patient stratification, treatment-response research, target discovery and multiomic integration.
📅 Sept 28–Oct 2
📍 Booth Q.03
Come and meet the Metabolon team!
Only 15 days left to apply for this quarter’s Metabolon Peak Science Grant! 🔬
One winning project will receive a fully funded metabolomics study, including analysis of up to 100 qualified samples.
Apply by September 30: bit.ly/4wP3M2t
At Alliance Against Cancer in Naples?
Tomorrow, Dr. Kristi Buzo of IRCC Candiolo Cancer Institute will present research featuring Metabolon data, exploring WEE1 inhibition to overcome resistance to EGFR blockade in colorectal cancer.
📅 Sept 11 | 14:40
Don't miss it!
Attending #MANA2026 and curious about Metabolon Verus™?
Join Heino Heyman tomorrow to see the data behind its performance across independent labs.
📢 One Kit. Multiple Labs. Reproducible Biochemistry. Now in Your Lab.
📅 Sept 10 | 12 PM
📍 UC Davis
Commercial orders for Metabolon Verus™ are now open!
Bring standardized, reproducible metabolomics into your lab, backed by 25+ years of Metabolon expertise.
🔗 Order now: bit.ly/3UXAxfJ
Shipping begins October 1. International availability coming in early 2027.
🎥 Friday Feature: On-Demand Webinars
How can metabolomics connect diet to health?
Dr. Dorrain Lowe explores how metabolite-based dietary scores can help reveal relationships between dietary patterns, disease, and health outcomes.
Watch: bit.ly/4iMdgr0
We’re heading to UC Davis for #MANA2026!
Join us Sept. 8–11 to discover the Metabolon Verus™ Metabolomics Profiling Kit, bringing standardized, high-quality metabolomics directly into your lab.
Plus, stay tuned for details on our lunch presentation!
See you in Davis! 👋
🎥 Friday Feature: On-Demand Webinars
What can we learn when we connect genomics with metabolomics?
Dr. Russell P. Bowler explores how combining both can reveal links between genetic variants, metabolites, and metabolic risk.
Watch: bit.ly/4qFeNky